Finance

Lists
ONCO:STO
Oncopeptides AB
SEK 1.79
-5.45%
(-0.10) 1D
Sep 4, 2:37:36 PM GMT+2  ·   SEK
All symbols
SymbolPriceChange% Change
Generating top insights for ONCO...
Open
SEK 1.90
High
SEK 1.94
Low
SEK 1.77
Mkt. cap
678.94M
Avg. vol.
2.83M
Volume
3.04M
52-wk high
SEK 6.18
52-wk low
SEK 1.26
EPS
-SEK 0.77
Shares outstanding
381.15M
No. of employees
69
Open
SEK 1.90
High
SEK 1.94
Low
SEK 1.77
Mkt. cap
678.94M
Avg. vol.
2.83M
Volume
3.04M
52-wk high
SEK 6.18
52-wk low
SEK 1.26
EPS
-SEK 0.77
Shares outstanding
381.15M
No. of employees
69
About Oncopeptides AB
CEO-
Employees69
Founded2000
Headquarters-
SectorBiotechnology
Previous reportsAll values in SEK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in SEK
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
20.21M
18.57M
25.38M
31.10M
Cost of goods sold
288.00K
1.85M
320.00K
966.00K
Cost of revenue
288.00K
1.85M
320.00K
966.00K
Research and development expenses
17.29M
35.90M
21.49M
23.53M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
50.91M
43.19M
44.27M
57.56M
Operating expense
66.98M
79.23M
62.60M
78.80M
Total operating expenses
67.27M
81.08M
62.92M
79.77M
Operating income
-47.05M
-62.52M
-37.53M
-48.67M
Other non operating income
-1.00K
-12.33M
1.00K
-
EBT including unusual items
-60.76M
-63.99M
-32.06M
-54.60M
EBT excluding unusual items
-60.76M
-63.28M
-32.06M
-54.60M
Income tax expense
139.00K
1.18M
123.00K
108.00K
Effective tax rate
-0.23%
-1.85%
-0.38%
-0.20%
Other operating expenses
-1.22M
139.00K
-3.17M
-2.29M
Net income
-60.89M
-65.17M
-32.18M
-54.71M
Net profit margin
-301.25%
-351.02%
-126.79%
-175.93%
Earnings per share
-
-
-
-
Interest and investment income
-
8.55M
5.47M
-
Interest expense
-13.70M
-
-
-5.94M
Net interest expenses
-13.70M
8.55M
5.47M
-5.94M
Depreciation and amortization charges
-
-
-
-
EBITDA
-46.43M
-61.95M
-36.96M
-48.10M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more
Google apps